The research collaboration opens up treatment possibilities for diseases in areas like oncology, cardiometabolic disorders, ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage biotechnology company Capstan Therapeutics, Inc., in a bid to boost its ...

San Diego-based Capstan is developing a potential first-in-class therapy to treat certain autoimmune disease by changing ...

STAT Brand Studio chatted with him to discuss six ways the company is ushering in a new era in immunology. 1. Deepening our understanding of patients’ needs.